Second, the negative prognostic impact of FOXP1-SHQ1 deletion attributable largely to FOXP1 loss suggests FOXP1 may have tumor suppressor activity, consistent with the known suppressive effects of FOXP1 on hormone receptor signaling16, 17. This evidence concerns the gene NR4A1 and neoplasm.